Division of Gastroenterology, Department of Internal Medicine.
Department of Internal Medicine.
J Clin Gastroenterol. 2022 Feb 1;56(2):e145-e148. doi: 10.1097/MCG.0000000000001513.
Coronavirus disease 2019 (COVID-19) has taken hundreds of thousands of lives globally. Besides the respiratory tract, the virus can affect the gastrointestinal (GI) tract. Data regarding the significance of GI symptoms in the COVID-19 course are limited. In this largest US study to date, the authors reviewed electronic encounters of 1003 consecutive patients who were tested positive for the virus between March 12 and April 3, 2020. Initial GI symptoms were present in up to 22.4% of patients and were associated with worse outcomes after adjustment for demographics, comorbidities, and other clinical symptoms. COVID-19 with GI involvement may define a more severe phenotype.
2019 年冠状病毒病(COVID-19)已在全球夺走了数十万人的生命。除了呼吸道,该病毒还会影响胃肠道(GI)道。有关 COVID-19 病程中胃肠道症状重要性的数据有限。在这项迄今为止美国最大的研究中,作者回顾了 2020 年 3 月 12 日至 4 月 3 日期间连续 1003 例病毒检测呈阳性患者的电子就诊记录。最初的胃肠道症状在多达 22.4%的患者中出现,并在调整了人口统计学、合并症和其他临床症状后与较差的结局相关。伴有胃肠道受累的 COVID-19 可能定义了更严重的表型。